{"id":7180,"date":"2026-01-01T05:26:52","date_gmt":"2026-01-01T05:26:52","guid":{"rendered":"https:\/\/dexpatent.com\/insights\/?p=7180"},"modified":"2026-01-08T07:55:30","modified_gmt":"2026-01-08T07:55:30","slug":"enveric-biosciences-gets-new-neuropsychiatric-patent","status":"publish","type":"post","link":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/","title":{"rendered":"Enveric Biosciences receives new patent for neuropsychiatric treatments"},"content":{"rendered":"

\"Enveric<\/p>\n

Enveric Biosciences receives new patent for neuropsychiatric treatments<\/h2>\n

Enveric Biosciences has received patent that discloses novel molecules with potential applications for mental health disorders. The patent discloses compounds based on known substances with relevant pharmacological activity but chemically altered to potentially improve efficacy and reduce side effects. (Source – Ng.investing)<\/em><\/p>\n

Sony patents native backwards compatibility with all previous consoles<\/h2>\n

A recent patent registered by Sony Interactive Entertainment shows a change for the future PlayStation 6. The proposed innovation differs from current methods by focusing on a hardware-based solution, eliminating dependence on software emulation or cloud streaming services. (Source – Mixvale)<\/em><\/p>\n

Mercedes-Benz patents palm-vein biometric car access<\/h2>\n

Mercedes-Benz has patented for palm-vein biometric car access using infrared scanner and low-power sensors, encrypting data and limiting EV range impact. The patent outlines a system in which an infrared camera reads the vein pattern in a hand and uses biometrics to decide whether to unlock the doors and start the vehicle. (Source – Speedme)<\/em><\/p>\n

Co-Diagnostics receives Australian patent for its novel Co-Dx PCR Platform Technologies<\/h2>\n

Co-Diagnostics, Inc., a molecular diagnostics company has received a unique, patented platform for the development of molecular diagnostic tests. This is the first patent granted for the new platform and provides broad protection in Australia for the Company’s proprietary system and methods used for nucleic acid detection and analysis. (Source – Prnewswire)<\/em><\/p>\n

\"Inventor<\/a><\/p>\n

Safe Pro files patent for enhanced AI Algorithm for improved detection in drone operations<\/h2>\n

Safe Pro Group Inc filed its latest patent application<\/a> for its AI-powered computer vision technology for detection of small explosive threats in drone-based video and imagery. The patent application describes a novel approach that significantly enhances the detection precision and accuracy of AI<\/a>, when used to detect small objects in imagery captured by drones. (Source – Businesswire)<\/em><\/p>\n

GM patent application explores remote vehicle control<\/h2>\n

GM files patent application for remote vehicle control. The patent application<\/a> describes a system designed to deliver precise control over steering, braking, acceleration, and transmission functions, even in scenarios requiring fine inputs, such as navigating narrow spaces or operating on sloped or banked surfaces. (Source \u2013 Gmauthority)<\/em><\/p>\n

Zefr awarded patent for AI-Powered Content Classification Process<\/h2>\n

Zefr, a global leader in brand suitability technology for social platforms has received a new patent covering its proprietary AI-driven process for content annotation and model distillation. The patented method enables AI agents to query massive video datasets, identify ambiguous or underspecified cases, and escalate only the most complex examples for targeted human review. (Source – Businesswire)<\/em><\/p>\n

Datavault AI Inc. receives two patents for Advancing Blockchain-Driven Content Licensing and Tokenized Monetization<\/h2>\n

Datavault AI Inc. receives two key U.S. patents relating to blockchain-based content management and monetization. The two newly issued patents<\/a> cover groundbreaking systems and methods for secure content licensing and tokenized monetization using blockchain technology and smart contracts. (Source – Globenewswire)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Enveric Biosciences receives new patent for neuropsychiatric treatments Enveric Biosciences has received patent that discloses novel molecules with potential applications for mental health disorders. The patent discloses compounds based on known substances with relevant pharmacological activity but chemically altered to potentially improve efficacy and reduce side effects. (Source – Ng.investing) […]<\/p>\n","protected":false},"author":1,"featured_media":7185,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","om_disable_all_campaigns":false,"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[316],"class_list":["post-7180","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patentnewzbox","tag-neuropsychiatric-treatments"],"aioseo_notices":[],"yoast_head":"\nEnveric Biosciences receives new patent for neuropsychiatric treatments - Patent Insights | DexPatent<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enveric Biosciences receives new patent for neuropsychiatric treatments - Patent Insights | DexPatent\" \/>\n<meta property=\"og:description\" content=\"Enveric Biosciences receives new patent for neuropsychiatric treatments Enveric Biosciences has received patent that discloses novel molecules with potential applications for mental health disorders. The patent discloses compounds based on known substances with relevant pharmacological activity but chemically altered to potentially improve efficacy and reduce side effects. (Source – Ng.investing) […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/\" \/>\n<meta property=\"og:site_name\" content=\"Patent Insights | DexPatent\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-01T05:26:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-08T07:55:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2026\/01\/enveric-header-v1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"760\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Linda Raj\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Linda Raj\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/\"},\"author\":{\"name\":\"Linda Raj\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#\\\/schema\\\/person\\\/5beb3a2bbcb43ffb10f5ded5914d163a\"},\"headline\":\"Enveric Biosciences receives new patent for neuropsychiatric treatments\",\"datePublished\":\"2026-01-01T05:26:52+00:00\",\"dateModified\":\"2026-01-08T07:55:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/\"},\"wordCount\":478,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/enveric-header-v1.png\",\"keywords\":[\"#neuropsychiatric treatments\"],\"articleSection\":[\"Patent Newz Box\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/\",\"url\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/\",\"name\":\"Enveric Biosciences receives new patent for neuropsychiatric treatments - Patent Insights | DexPatent\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/enveric-header-v1.png\",\"datePublished\":\"2026-01-01T05:26:52+00:00\",\"dateModified\":\"2026-01-08T07:55:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#\\\/schema\\\/person\\\/5beb3a2bbcb43ffb10f5ded5914d163a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/enveric-header-v1.png\",\"contentUrl\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/enveric-header-v1.png\",\"width\":760,\"height\":450,\"caption\":\"Enveric Biosciences receives new patent for neuropsychiatric treatments\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/2026\\\/01\\\/01\\\/enveric-biosciences-gets-new-neuropsychiatric-patent\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enveric Biosciences receives new patent for neuropsychiatric treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#website\",\"url\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/\",\"name\":\"Patent Insights | DexPatent\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/#\\\/schema\\\/person\\\/5beb3a2bbcb43ffb10f5ded5914d163a\",\"name\":\"Linda Raj\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9cd9ca7f0f5221039773e717deef1874b3e34453923db6a7bb9bbf2c806c8844?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9cd9ca7f0f5221039773e717deef1874b3e34453923db6a7bb9bbf2c806c8844?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9cd9ca7f0f5221039773e717deef1874b3e34453923db6a7bb9bbf2c806c8844?s=96&d=mm&r=g\",\"caption\":\"Linda Raj\"},\"description\":\"Linda, Lead Patent Scientist at DexPatent, is dedicated to aiding IP Counsel and Patent attorneys in Patent research and management. Her interests span from reading books to writing on subjects related to innovation, work, and life.\",\"sameAs\":[\"https:\\\/\\\/dexpatent.com\\\/insights\"],\"url\":\"https:\\\/\\\/dexpatent.com\\\/insights\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enveric Biosciences receives new patent for neuropsychiatric treatments - Patent Insights | DexPatent","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/","og_locale":"en_US","og_type":"article","og_title":"Enveric Biosciences receives new patent for neuropsychiatric treatments - Patent Insights | DexPatent","og_description":"Enveric Biosciences receives new patent for neuropsychiatric treatments Enveric Biosciences has received patent that discloses novel molecules with potential applications for mental health disorders. The patent discloses compounds based on known substances with relevant pharmacological activity but chemically altered to potentially improve efficacy and reduce side effects. (Source – Ng.investing) […]","og_url":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/","og_site_name":"Patent Insights | DexPatent","article_published_time":"2026-01-01T05:26:52+00:00","article_modified_time":"2026-01-08T07:55:30+00:00","og_image":[{"width":760,"height":450,"url":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2026\/01\/enveric-header-v1.png","type":"image\/png"}],"author":"Linda Raj","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Linda Raj","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/#article","isPartOf":{"@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/"},"author":{"name":"Linda Raj","@id":"https:\/\/dexpatent.com\/insights\/#\/schema\/person\/5beb3a2bbcb43ffb10f5ded5914d163a"},"headline":"Enveric Biosciences receives new patent for neuropsychiatric treatments","datePublished":"2026-01-01T05:26:52+00:00","dateModified":"2026-01-08T07:55:30+00:00","mainEntityOfPage":{"@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/"},"wordCount":478,"commentCount":0,"image":{"@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/#primaryimage"},"thumbnailUrl":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2026\/01\/enveric-header-v1.png","keywords":["#neuropsychiatric treatments"],"articleSection":["Patent Newz Box"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/","url":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/","name":"Enveric Biosciences receives new patent for neuropsychiatric treatments - Patent Insights | DexPatent","isPartOf":{"@id":"https:\/\/dexpatent.com\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/#primaryimage"},"image":{"@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/#primaryimage"},"thumbnailUrl":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2026\/01\/enveric-header-v1.png","datePublished":"2026-01-01T05:26:52+00:00","dateModified":"2026-01-08T07:55:30+00:00","author":{"@id":"https:\/\/dexpatent.com\/insights\/#\/schema\/person\/5beb3a2bbcb43ffb10f5ded5914d163a"},"breadcrumb":{"@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/#primaryimage","url":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2026\/01\/enveric-header-v1.png","contentUrl":"https:\/\/dexpatent.com\/insights\/wp-content\/uploads\/2026\/01\/enveric-header-v1.png","width":760,"height":450,"caption":"Enveric Biosciences receives new patent for neuropsychiatric treatments"},{"@type":"BreadcrumbList","@id":"https:\/\/dexpatent.com\/insights\/2026\/01\/01\/enveric-biosciences-gets-new-neuropsychiatric-patent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dexpatent.com\/insights\/"},{"@type":"ListItem","position":2,"name":"Enveric Biosciences receives new patent for neuropsychiatric treatments"}]},{"@type":"WebSite","@id":"https:\/\/dexpatent.com\/insights\/#website","url":"https:\/\/dexpatent.com\/insights\/","name":"Patent Insights | DexPatent","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dexpatent.com\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/dexpatent.com\/insights\/#\/schema\/person\/5beb3a2bbcb43ffb10f5ded5914d163a","name":"Linda Raj","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9cd9ca7f0f5221039773e717deef1874b3e34453923db6a7bb9bbf2c806c8844?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9cd9ca7f0f5221039773e717deef1874b3e34453923db6a7bb9bbf2c806c8844?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9cd9ca7f0f5221039773e717deef1874b3e34453923db6a7bb9bbf2c806c8844?s=96&d=mm&r=g","caption":"Linda Raj"},"description":"Linda, Lead Patent Scientist at DexPatent, is dedicated to aiding IP Counsel and Patent attorneys in Patent research and management. Her interests span from reading books to writing on subjects related to innovation, work, and life.","sameAs":["https:\/\/dexpatent.com\/insights"],"url":"https:\/\/dexpatent.com\/insights\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/posts\/7180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/comments?post=7180"}],"version-history":[{"count":3,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/posts\/7180\/revisions"}],"predecessor-version":[{"id":7186,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/posts\/7180\/revisions\/7186"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/media\/7185"}],"wp:attachment":[{"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/media?parent=7180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/categories?post=7180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dexpatent.com\/insights\/wp-json\/wp\/v2\/tags?post=7180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}